Skip to main content
PeptiDex - Peptide Research and Education Platform
PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Research Disclaimer

All information on PeptiDex is for educational and research purposes only. None of the compounds discussed are FDA-approved for human consumption unless explicitly noted (e.g., Semaglutide under prescription). Always consult a qualified medical professional before considering any peptide protocol. The vendors listed operate as raw chemical and laboratory supply companies. Their products are intended solely for authorized laboratory, educational, and research purposes. PeptiDex does not sell, distribute, or endorse any compound for human or animal use.

PeptiDex

The independent, evidence-based peptide research index. Trusted by researchers worldwide.

Learn & Research

  • Peptide 101 Hub
  • Peptide Library
  • Evidence Dashboard
  • Research Blog
  • FAQ

Compare & Source

  • Vendor Reviews
  • Price Comparison
  • Compare Tool
  • Cycle Planner
  • Community Stacks

Recent Articles

  • Tesamorelin: What Sets It Apart from Every Other Growth Hormone Peptide
  • Peptide Stacking in 2026: Why Combination Protocols Are Redefining Results
  • The 2026 FDA Peptide Reclassification: What It Means for Patients, Providers, and the Future of Peptide Therapy

© 2026 PeptiDex. All rights reserved.

About UsEditorial PolicyMedical DisclaimerPrivacy & Terms
Home
Library
BlogStartToolsSaved
All Blends
🛡️

BPC-157 / KPV

"The Gut Healer"

BPC-157KPVGut Health

Benefits

Gut healing, IBD relief, reduced intestinal inflammation, mucosal repair

Why This Blend?

BPC-157's tissue repair meets KPV's potent NF-κB suppression. BPC-157 heals the physical damage while KPV turns off the inflammatory signaling causing it. The ultimate gut restoration protocol.

Mechanism of Action

BPC-157 promotes GI mucosal healing via cytoprotective pathways and angiogenesis. KPV (alpha-MSH fragment) powerfully suppresses NF-κB inflammatory signaling and reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in intestinal epithelium.

Dosing Protocol

Typical Ratio: BPC-157 500mcg + KPV 200-500mcg

BPC-157 250-500mcg SubQ + KPV 200-500mcg orally or SubQ. KPV oral capsules target gut directly. Cycle 4-12 weeks.

Expected Timeline

Week 1

Rapid reduction in gut inflammation; improved GI comfort

Weeks 2–4

Mucosal healing; reduced bloating and IBS/IBD symptoms

Months 2–3

Significant GI restoration; normalized bowel function

Long-term

Sustained gut health; potential remission of chronic GI conditions

Supporting Studies

BPC-157 GI tract healing

BPC-157 heals GI ulcers, fistulas, and inflammatory bowel lesions.

preclinical

KPV anti-inflammatory effects in colitis

KPV suppresses NF-κB and MAPK pathways in inflammatory bowel disease models.

preclinical

Safety Notes

Both peptides have excellent safety profiles. KPV can be taken orally for gut-specific effects. Not FDA-approved.

📚 Individual Peptide Profiles

BPC-157 →KPV →